Cryo Cell International (CCEL) Gains from Investment Securities (2019 - 2024)
Cryo Cell International (CCEL) posted quarterly Gains from Investment Securities of -$1035.0 for Q4 2024, up 99.9% year-over-year from -$517.77 in Q4 2023, and down 108.15% quarter-over-quarter from $12702.0 in Q3 2024.
Cryo Cell International (CCEL) Gains from Investment Securities (2019 - 2024) Analysis & Trends
Cryo Cell International (CCEL) has reported Gains from Investment Securities for 6 consecutive years, with -$1035.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Gains from Investment Securities rose 99.9% year-over-year to -$1035.0; the TTM figure through Nov 2024 stood at $2794.0 (up 100.27% YoY), while the FY2024 annual figure was $2794.0, up 100.27% from the prior year.
- Gains from Investment Securities retreated to -$1035.0 in Q4 2024 per CCEL's latest filing, from $12702.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $412307.0 in Q3 2022 and bottomed at -$1.8 million in Q4 2020.
- Historically, Gains from Investment Securities has averaged -$241092.4 across 5 years, with a median of -$43758.5 in 2020.
- On a YoY basis, Gains from Investment Securities climbed as much as 396.42% in 2021 and fell as far as 1673.86% in 2021.
- Cryo Cell International's Gains from Investment Securities stood at -$1.8 million in 2020, then soared by 89.93% to -$178372.0 in 2021, then tumbled by 634.84% to -$1.3 million in 2022, then rose by 24.79% to -$985824.0 in 2023, then soared by 99.9% to -$1035.0 in 2024.
- Business Quant data shows CCEL's Gains from Investment Securities at -$1035.0 in Q4 2024, $12702.0 in Q3 2024, and -$3697.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2024 | -1,035.00 |
| Nov 30, 2024 | -1,035.00 |
| Aug 31, 2024 | 12,702.00 |
| Aug 31, 2024 | 12,702.00 |
| May 31, 2024 | -3,697.00 |
| May 31, 2024 | -3,697.00 |
| Feb 29, 2024 | -5,176.00 |
| Feb 29, 2024 | -5,176.00 |
| Nov 30, 2023 | -985,824.00 |
| Nov 30, 2023 | -985,824.00 |
| Aug 31, 2023 | 122,671.00 |
| Aug 31, 2023 | 122,671.00 |
| May 31, 2023 | -23,124.00 |
| May 31, 2023 | -23,124.00 |
| Feb 28, 2023 | -164,701.00 |
| Feb 28, 2023 | -164,701.00 |
| Nov 30, 2022 | -1.31 Mn |
| Nov 30, 2022 | -1.31 Mn |
| Aug 31, 2022 | 412,307.00 |
| Aug 31, 2022 | 412,307.00 |